Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.

Micol R Lortholary O Sar B Laureillard D Ngeth C Dousset JP Chanroeun H Ferradini L Guerin PJ Dromer F Fontanet A
Journal of acquired immune deficiency syndromes (1999) 2007 Aug 15; 45(5); 555-9. doi: 10.1097/QAI.0b013e31811ed32c. Epub 2007 10 10

Abstract

OBJECTIVES: To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis.

METHODS: All HIV-infected patients with a CD4+ count

RESULTS: The median (interquartile range [IQR]) CD4+ count of 327 enrolled patients was 24 (IQR: 8 to 65) cells/mm3. The prevalence of cryptococcal infection was 59 (18.0%) of 327 cases, of which 41 were CM and 10 were IPCA. In the absence of serum CPS detection, 17 (28.8%) of 59 cryptococcal infections would have been missed on the day of consultation. In patients with no specific symptoms of meningoencephalitis, the prevalence of positive serum CPS detection was 32 (10.8%) of 295 cases. Countryside residence (adjusted odds ratio [AOR] = 3.6), headache (AOR = 3.2), body mass index

CONCLUSION: Serum CPS screening among AIDS patients with a CD4+ count